Patent ID: 7671075

Claim:
A method of lowering beta amyloid levels comprising: delivering to a patient, a pharmaceutically acceptable amount of a compound of Formula I: wherein: R 1 is selected from the group consisting of H and halogen; R 2 is selected from the group consisting of H and halogen; R 3 is selected from the group consisting of H and halogen; R 4 is selected from the group consisting of H and halogen; R 5 is selected from the group consisting of H and halogen; R 6 is H; R 7 is H; R 8 is lower alkyl; T is R 9 and R 10 are H; or R 9 is H and R 10 is selected from the group consisting of lower alkyl, lower alkenyl, methyl-substituted alkenyl, lower alkynyl, cycloalkyl, substituted phenyl, 1-naphthyl, and CH 2 CH 2 -1,3-dioxolane; or R 9 and R 10 are independently selected from the group consisting of lower alkyl, lower alkenyl, phenyl, 4-substituted-phenyl, and 1-naphthyl; wherein at least one of R 1 , R 2 , R 3 , R 4 , and R 5 is halogen; or a pharmaceutically acceptable salt thereof.